Material science, cell biology, and engineering are all part of the research field of tissue engineering.
The progress made in material science, cell biology, mechanobiology and bioreactor technology will be key to support advances in this challenging field.
Collectively, the interdisciplinary group has an unusual combination of expertise in the design and fabrication of scaffolds, material science, cell and molecular biology, and the culturing and seeding of human mesenchymal cells.
Interest has therefore turned increasingly to the field of tissue engineering, which applies the principles and methods of bioengineering, material science, cell transplantation, and the life sciences in an effort to develop in vitro biological substitutes that can restore, maintain, or improve tissue and organ function.
Coupled with materials science, cell biology, biochemistry, and gene techniques, some novel approaches have been developed to overcome the current challenges such as enhancing angiogenesis, inhibiting scarring, and regenerating appendages.
Regenerative engineering is defined as the integration of tissue engineering with advanced material science, stem cell science, biophysical stimulation, and areas of developmental biology.
The regenerative engineering techniques offer a novel solution by converging the fields of tissue engineering, advanced material science, stem cell science, physics, developmental biology, and clinical translation for the reconstruction of soft tissue.
Recent progress in chemistry, material science, and cell biology have made possible the control of the extracellular environment (soluble factors and also cell substrate signaling) in in vitro systems.
Regenerative engineering converges tissue engineering, advanced materials science, stem cell science, and developmental biology to regenerate complex tissues such as whole limbs.
Regenerative engineering the convergence of tissue engineering with advanced materials science, stem cell science, and developmental biology represents the next valuable tool to overcome the challenges.
A multidisciplinary approach involving materials science, stem cell biology, biomolecular design, engineering, medical physics, and informatics have created translational opportunities for the development of novel therapies whose results in preclinical and clinical trials are promising.
